PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature
Authors
Keywords
-
Journal
Future Oncology
Volume 10, Issue 14, Pages 2259-2277
Publisher
Future Medicine Ltd
Online
2014-12-04
DOI
10.2217/fon.14.139
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection of Metastatic Insulinoma by Positron Emission Tomography With [68Ga]Exendin-4—A Case Report
- (2014) Olof Eriksson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of Time-of-Flight and Point-Spread-Function in SUV Quantification for Oncological PET
- (2013) Elena Prieto et al. CLINICAL NUCLEAR MEDICINE
- Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature
- (2013) M Fraenkel et al. ENDOCRINE-RELATED CANCER
- Grading the neuroendocrine tumors of the lung: an evidence-based proposal
- (2013) G Rindi et al. ENDOCRINE-RELATED CANCER
- A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma
- (2013) Alexander Kroiss et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Simultaneous 68Ga-DOTATOC PET/MRI in Patients With Gastroenteropancreatic Neuroendocrine Tumors
- (2013) Karsten J. Beiderwellen et al. INVESTIGATIVE RADIOLOGY
- Evaluation of Feasibility and Image Quality of 68Ga-DOTATOC Positron Emission Tomography/Magnetic Resonance in Comparison With Positron Emission Tomography/Computed Tomography in Patients With Neuroendocrine Tumors
- (2013) Florian C. Gaertner et al. INVESTIGATIVE RADIOLOGY
- Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT Within Patients with Gastroenteropancreatic Neuroendocrine Tumors
- (2013) D. Wild et al. JOURNAL OF NUCLEAR MEDICINE
- Measured Human Dosimetry of 68Ga-DOTATATE
- (2013) R. C. Walker et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours
- (2013) Emre Demirci et al. NUCLEAR MEDICINE COMMUNICATIONS
- Diagnostic performance of somatostatin receptor PET/CT using 68Ga-DOTANOC in gastrinoma patients with negative or equivocal CT findings
- (2012) Niraj Naswa et al. ABDOMINAL IMAGING
- Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia
- (2012) Vera Froeling et al. ANNALS OF NUCLEAR MEDICINE
- 68Ga-DOTANOC PET/CT in Patients With Carcinoma of Unknown Primary of Neuroendocrine Origin
- (2012) Niraj Naswa et al. CLINICAL NUCLEAR MEDICINE
- Semiquantitative Analysis and Characterization of Physiological Biodistribution of 68Ga-DOTA-TATE PET/CT
- (2012) Jolanta Kunikowska et al. CLINICAL NUCLEAR MEDICINE
- 68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET
- (2012) Valentina Ambrosini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours
- (2012) Levent Kabasakal et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide
- (2012) Daniel Putzer et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI
- (2012) F.L. Giesel et al. EUROPEAN JOURNAL OF RADIOLOGY
- High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours
- (2012) Michael S Hofman et al. Journal of Medical Imaging and Radiation Oncology
- Clinical PET of Neuroendocrine Tumors Using 64Cu-DOTATATE: First-in-Humans Study
- (2012) A. Pfeifer et al. JOURNAL OF NUCLEAR MEDICINE
- PET/MRI in cancer patients: first experiences and vision from Copenhagen
- (2012) Andreas Kjær et al. MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE
- ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Colorectal Neuroendocrine Neoplasms
- (2012) Martyn Caplin et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors
- (2012) Massimo Falconi et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas
- (2012) Ulrich-Frank Pape et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes
- (2012) Robert T. Jensen et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
- (2012) Marianne Pavel et al. NEUROENDOCRINOLOGY
- Gallium-68-DOTA-NOC PET/CT of Patients With Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Single-Center Study
- (2011) Niraj Naswa et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Ga-68 DOTA-NOC Uptake in the Pancreas
- (2011) Yodphat Krausz et al. CLINICAL NUCLEAR MEDICINE
- Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms
- (2011) Günter Klöppel ENDOCRINE-RELATED CANCER
- Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours
- (2011) Nils F. Schreiter et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Are contrast media required for (68)Ga-DOTATOC PET/CT in patients with neuroendocrine tumours of the abdomen?
- (2011) Marius E. Mayerhoefer et al. EUROPEAN RADIOLOGY
- Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours
- (2011) Nils F. Schreiter et al. EUROPEAN RADIOLOGY
- 68Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol
- (2011) J. Ruf et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors
- (2011) T. D. Poeppel et al. JOURNAL OF NUCLEAR MEDICINE
- Incidence of Increased 68Ga-DOTANOC Uptake in the Pancreatic Head in a Large Series of Extrapancreatic NET Patients Studied with Sequential PET/CT
- (2011) P. Castellucci et al. JOURNAL OF NUCLEAR MEDICINE
- First Clinical Evidence That Imaging with Somatostatin Receptor Antagonists Is Feasible
- (2011) D. Wild et al. JOURNAL OF NUCLEAR MEDICINE
- Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas
- (2011) D. Wild et al. JOURNAL OF NUCLEAR MEDICINE
- The Impact of 68Ga-DOTATOC Positron Emission Tomography/Computed Tomography on the Multimodal Management of Patients With Neuroendocrine Tumors
- (2010) Andrea Frilling et al. ANNALS OF SURGERY
- 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors
- (2010) T. Binderup et al. CLINICAL CANCER RESEARCH
- Ga-68 DOTATOC PET, Endoscopic Ultrasonography, and Multidetector CT in the Diagnosis of Duodenopancreatic Neuroendocrine Tumors
- (2010) Annibale Versari et al. CLINICAL NUCLEAR MEDICINE
- ‘Running on empty’
- (2010) Damian Wild et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analog
- (2010) Jean Claude Reubi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours
- (2010) Valentina Ambrosini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Standardized Uptake Values of 68Ga-DOTANOC PET: A Promising Prognostic Tool in Neuroendocrine Tumors
- (2010) D. Campana et al. JOURNAL OF NUCLEAR MEDICINE
- Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET
- (2010) T. Binderup et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors
- (2010) V. Ambrosini et al. JOURNAL OF NUCLEAR MEDICINE
- The Role of 68Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on 111In-DTPA-Octreotide Scintigraphy
- (2010) R. Srirajaskanthan et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-DOTA-NOC PET/CT Imaging of Neuroendocrine Tumors: Comparison with 111In-DTPA-Octreotide (OctreoScan®)
- (2010) Yodphat Krausz et al. MOLECULAR IMAGING AND BIOLOGY
- Role of68Ga-DOTATOC PET/CT in the Evaluation of Primary Pulmonary Carcinoids
- (2010) Tarun Jindal et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT
- (2009) Vikas Prasad et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours
- (2009) Alexander Haug et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Glucagon-Like Peptide-1 Receptor Imaging for Localization of Insulinomas
- (2009) Emanuel Christ et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Highly Efficient In Vivo Agonist-Induced Internalization of sst2 Receptors in Somatostatin Target Tissues
- (2009) B. Waser et al. JOURNAL OF NUCLEAR MEDICINE
- A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors
- (2009) I. Kayani et al. JOURNAL OF NUCLEAR MEDICINE
- Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy
- (2009) D. Putzer et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid
- (2009) Valentina Ambrosini et al. NUCLEAR MEDICINE COMMUNICATIONS
- Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET
- (2008) Stefano Fanti et al. BIOMEDICINE & PHARMACOTHERAPY
- Functional imaging of neuroendocrine tumors with combined PET/CT using68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and18F-FDG
- (2008) Irfan Kayani et al. CANCER
- Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours
- (2008) Valentina Ambrosini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastroenteropancreatic neuroendocrine tumours
- (2008) Irvin M Modlin et al. LANCET ONCOLOGY
- Quantitative Gene Expression of Somatostatin Receptors and Noradrenaline Transporter Underlying Scintigraphic Results in Patients with Neuroendocrine Tumors
- (2008) Tina Binderup et al. NEUROENDOCRINOLOGY
- Glucagon-like Peptide 1–Receptor Scans to Localize Occult Insulinomas
- (2008) Damian Wild et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started